TPM
ELV icon

Triasima Portfolio Management’s Elevance Health ELV Stock Holding History

Triasima Portfolio Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,520
Closed -$1.62M – 142
2023
Q1 		$1.62M Sell
3,520
-7,142
-67% -$3.4M 0.13% 89
2022
Q4 		$5.47M Sell
10,662
-40
-0.4% -$20.3K 0.42% 43
2022
Q3 		$4.86M Buy
10,702
+420
+4% +$201K 0.39% 44
2022
Q2 		$4.96M Buy
10,282
+4,832
+89% +$2.39M 0.35% 44
2022
Q1 		$2.68M Buy
+5,450
New +$2.49M 0.13% 80

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Triasima Portfolio Management's ELV Position: Q2 2023 in Review

Triasima Portfolio Management sold out of Elevance Health (ELV) in Q2 2023, closing a stake of 3,520 shares — an estimated $1.62M sold.

Triasima Portfolio Management first reported a position in ELV in Q1 2022 and held it in 5 quarters. The position peaked at $5.47M in Q4 2022. 1,523 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

  • Triasima Portfolio Management reported no remaining Elevance Health position as of Q2 2023 after selling out during the quarter.
  • Triasima Portfolio Management sold 3,520 Elevance Health shares in Q2 2023, an estimated $1.62M.
  • Triasima Portfolio Management first reported a position in Elevance Health in Q1 2022 and held it in 5 quarters.
  • Triasima Portfolio Management's Elevance Health position peaked at $5.47M in Q4 2022.
  • 1,523 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on Triasima Portfolio Management's 13F filing for Q2 2023, filed 8 Aug 2023.